Another study indicated that intramuscular administration 300000 IU vitamin D supplement in type 2 diabetes (T2D) patients with ischemic heart disease had no significant changes in the levels of ICAM-1 and VCAM-1 [32]. This evidence concerns the gene VCAM1 and coronary artery disorder.